Related Experiment Video
Updated: Jun 8, 2026
04:03
Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
Published on: September 27, 2024
Modification of COPD presentation during the last 25 years
Antoine Fremault1, Wim Janssens, François Beaucage
1University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Belgium. antoine.fremault@uz.kuleuven.ac.be
COPD
|September 22, 2010
Summary
Chronic Obstructive Pulmonary Disease (COPD) patients show a more severe phenotype with lower FEV1 and increased comorbidities over 20 years. Improved COPD management is suggested by similar hospitalization lengths and survival rates despite disease progression.
Area of Science:
- Pulmonary Medicine
- Clinical Epidemiology
Background:
- Chronic Obstructive Pulmonary Disease (COPD) treatment has advanced.
- Understanding changes in COPD patient presentation over time is crucial for effective management.
Purpose of the Study:
- To compare the clinical characteristics and outcomes of COPD exacerbation patients from two distinct historical periods.
- To assess changes in COPD patient phenotype, comorbidities, and treatment over approximately two decades.
Main Methods:
- Retrospective comparison of two random patient cohorts admitted for COPD exacerbation: 1980-1984 (n=51) and 2001-2005 (n=101).
- Analysis included FEV1, age, gender, BMI, Charlson's comorbidity index, hemoglobin levels, anemia prevalence, medication use, hospitalization duration, and 30-month survival.
Main Results:
- The 2001-2005 cohort exhibited significantly lower FEV1 (48% vs. 41% predicted) and a higher prevalence of comorbidities, including anemia.
- Increased use of cardiovascular and respiratory medications was observed in the recent cohort, with no change in long-term oxygen therapy.
- Despite a more severe presentation, hospitalization length (13.6 vs. 12.7 days) and 30-month survival (66.6% vs. 69.3%) remained statistically similar between cohorts.
Conclusions:
- COPD patients admitted for exacerbations present with a more severe phenotype, characterized by lower FEV1 and increased comorbidities, compared to two decades prior.
- The stability in hospitalization length and survival suggests potential improvements in COPD management strategies over time.
- Further research into contemporary COPD management practices is warranted to explain the maintained outcomes despite disease progression.
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...